New York Attorney General Eric Schneiderman plans to announce a settlement Wednesday with U.S. units of Ranbaxy Laboratories Ltd. and Teva Pharmaceutical Industries Ltd. over allegations the two rival generic drug makers made an unlawful agreement to restrict competition.. Mr. Schneiderman's office confirmed the settlement. As part of the deal, the companies will terminate an agreement not to challenge each other's rights to sell certain generic drugs exclusively in the U.S. They also agreed to refrain from entering into similar...
  